Easy to get in contact with
fragilis can release a unique pro-inflammatory LPS-subtype and fragilysin, leading to an impaired intestinal paracellular and transcellular epithelial barrier, thereby allowing an already leaky barrier a gateway for the enhanced entry of microbiome-derived neuro- and entero-toxins into the circulation (Lukiw et al., 2021)
Screenshot_20260101_083835_Google10802340 259 KB 1 Like Beth January 1, 2026, 5:12pm #23 Excellent question @Nick1, and I have no idea yet I hope some smarter people than I am chime in hellooooo everyone
At THE RE/ CLINIC in Sandy, Utah , weve seen promising outcomes using peptide therapy to support gut health in patients dealing with chronic inflammation, including diverticulitis
That is established pharmacokinetics